Intel ( INTC ) reported earnings yesterday afternoon, and while results beat expectations on both the top and bottom line, the headline numbers mask the deeper debate surrounding the stock. Earnings rose 15% year over year and revenue declined 4%, though Q1 remains a seasonally weak period for Intel's businesses.

First Western Financial, Inc. (MYFW) Q4 2025 Earnings Call Transcript

Bristol-Myers Squibb (BMY) remains a Strong Buy as it accelerates Growth Portfolio revenues and executes strategic oncology expansion. BMY's collaboration with Janux Therapeutics positions it to enter the solid tumor market, leveraging TRACTr technology for long-term oncology growth. Camzyos delivered 89% YoY revenue growth and promising phase 3 SCOUT-HCM results, supporting potential label expansion to adolescent oHCM patients.

Contributions enhance Healthy Planet, Youth Movement and Nutrition CHANHASSEN, Minn., Jan. 23, 2026 /PRNewswire/ -- As 18,500 runners from around the world converge on Miami's streets for the Life Time Miami Marathon and Half Marathon Weekend, the Life Time Foundation prepares to make an impact of its own, fueled by its commitment to youth movement, youth nutrition, and a healthier planet.

Amerant Bancorp Inc. (AMTB) Q4 2025 Earnings Call Transcript

New York, New York--(Newsfile Corp. - January 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline. SO WHAT: If you purchased Ardent Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Novo Nordisk A/S stock has jumped 30% since my last coverage. NVO's first-mover advantage in oral GLP-1 positions it well despite rising competition and pricing pressures in obesity and diabetes markets. The company's long-term prospects are bright, and NVO stock appears undervalued.

Microsoft stock (NASDAQ: MSFT) jumped about 4% today, putting the tech heavyweight back in the spotlight as investors reassess both its fundamentals and its valuation. An industry comparison from Benzinga suggests Microsoft continues to stand out versus software peers on growth, profitability, and balance sheet strength, even as the signals across valuation metrics remain mixed.

The TappAlpha Innovation 100 Growth & Daily Income ETF offers superior income consistency, higher yield, and tax efficiency versus the ProShares Nasdaq-100 High Income ETF. TDAQ's active management enables better distribution targeting, dynamic option strategies, and more consistent payouts, with a recent annualized yield of 17.75%. TDAQ's structure allows for tax-loss harvesting and favorable 60/40 capital gains treatment, while IQQQ's swap-based approach is less tax-efficient.

The 63-year-old's pay packet is up from $38 million in 2024, according to a regulatory filing.

LOS ANGELES, Jan. 23, 2026 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against SLM Corporation a/k/a Sallie Mae ("SLM" or the "Company") (NASDAQ: SLM). IF YOU SUFFERED A LOSS ON YOUR SLM INVESTMENTS, CLICK HERE BEFORE FEBRUARY 17, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

Commodities of all kinds have been performing especially well as of late. Uranium is especially well-positioned to navigate 2026's markets.

Alcoa Corp. NYSE: AA delivered a strong fourth-quarter earnings report after the market closed on Jan. 22. The industrials giant delivered a beat on the top and bottom lines with earnings per share (EPS) of $1.26, beating estimates for 95 cents.

BENSALEM, Pa., Jan. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.

BENSALEM, Pa., Jan. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.

BENSALEM, Pa., Jan. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.

LOS ANGELES, Jan. 23, 2026 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Bitdeer Technologies Group ("Bitdeer" or the "Company") (NASDAQ: BTDR). IF YOU SUFFERED A LOSS ON YOUR BITDEER INVESTMENTS, CLICK HERE BEFORE FEBRUARY 2, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

Regeneron Pharmaceuticals, Inc. is approaching a pivotal earnings report following a strong JP Morgan Healthcare Conference update. I maintain a Buy rating on REGN, supported by a >16% share price gain since my last note. Despite recent gains, REGN trades well below its ~$1,200 all-time high from August 2024.

BENSALEM, Pa., Jan. 23, 2026 /PRNewswire/ -- The Law Offices of Howard G.

NEW YORK, Jan. 23, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. So What: If you purchased Simulations Plus securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.